Načítá se...
Targeting DDX3 in Medulloblastoma Using the Small Molecule Inhibitor RK-33
Medulloblastoma is the most common malignant tumor that arises from the cerebellum of the central nervous system. Clinically, medulloblastomas are treated by surgery, radiation, and chemotherapy, all of which result in toxicity and morbidity. Recent reports have identified that DDX3, a member of the...
Uloženo v:
Hlavní autoři: | , , , , , , , , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Elsevier
2019-01-01
|
Edice: | Translational Oncology |
On-line přístup: | http://www.sciencedirect.com/science/article/pii/S1936523318303097 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|